Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Androgen for Leydig Cell Proliferation (ALCeP)

This study has been completed.
Information provided by (Responsible Party):
Andrea M. Isidori, University of Roma La Sapienza Identifier:
First received: September 9, 2010
Last updated: October 25, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)